Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Form 8.3 - Willis Towers Watson plc

20th Aug 2020 11:11

 

Ap19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

 Name of person dealing (Note 1)Barclays PLC.
 Company dealt inWILLIS TOWERS WATSON PLC
 Class of relevant security to which the ORD
 dealings being disclosed relate (Note 2)
 Date of dealing19 August 2020

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Class of relevant security:ORD  
 

Long

Short

 

Number

(%)

Number

(%)

(1)

Relevant securities

 

 

 

 

 

1,512,976

1.17%

472,266

0.37%

  

 

 

 

 

(2)

Derivatives (other than options):

 

 

 

 

 

355,000

0.28%

383,659

0.30%

  

 

 

 

 

(3)

Options and agreements to

 

 

 

 

purchase/sell:

0

0.00%

0

0.00%

 

 

 

 

 

TOTAL:

 

 

 

 

 

1,867,976

1.45%

855,925

0.66%

 

 

 

 

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

 

 

 

(2) Derivatives (other than options)

 

 

 

(3) Options and agreements to purchase/sell

 

 

Total

 

 

 

Ap20

1. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale

Number of relevant securities

Price per unit

Purchase

7

204.2800 USD

Purchase

8

201.5700 USD

Purchase

9

201.0533 USD

Purchase

100

201.9498 USD

Purchase

200

202.8900 USD

Purchase

200

204.1950 USD

Purchase

280

202.9900 USD

Purchase

300

203.5350 USD

Purchase

300

203.6566 USD

Purchase

336

201.0000 USD

Purchase

340

203.1515 USD

Purchase

543

203.6118 USD

Purchase

600

203.9891 USD

Purchase

700

203.6950 USD

Purchase

704

203.3573 USD

Purchase

800

203.8550 USD

Purchase

900

203.7038 USD

Purchase

2,110

203.6666 USD

Purchase

3,000

203.7781 USD

Purchase

3,170

203.2545 USD

Purchase

5,853

203.3516 USD

Purchase

8,496

203.5834 USD

Purchase

8,765

203.3000 USD

Purchase

9,881

203.7350 USD

Purchase

11,132

203.6587 USD

Purchase

18,653

203.6581 USD

Purchase

22,432

203.5122 USD

Sale

6

199.9300 USD

Sale

8

201.5700 USD

Sale

100

202.1300 USD

Sale

100

203.3800 USD

Sale

121

203.0966 USD

Sale

121

203.2605 USD

Sale

200

203.2700 USD

Sale

204

203.3896 USD

Sale

336

201.0000 USD

Sale

384

203.4048 USD

Sale

400

203.6650 USD

Sale

1,161

203.6001 USD

Sale

1,400

203.1157 USD

Sale

1,529

203.3014 USD

Sale

2,010

203.3897 USD

Sale

3,470

203.3000 USD

Sale

7,120

203.3388 USD

Sale

10,494

203.6754 USD

Sale

10,514

203.6628 USD

Sale

21,848

203.5056 USD

Sale

37,306

203.6581 USD

(b) Derivatives transactions (other than options transactions)

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit

(Note 5)

 

 

 

 

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

 

 

 

 

 

 

 

(ii) Exercising

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

 

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

 

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None

Is a Supplemental Form 8 (Open Positions) attached?NO
Date of disclosure:

20 Aug 2020

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

If a connected EFM, name of offeree/offeror with which connected 
If a connected EFM, state nature of connection 

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20200820005384/en/

Copyright Business Wire 2020


Related Shares:

Barclays
FTSE 100 Latest
Value9,095.73
Change-5.04